Hypersensitivity pneumonitis: current concepts and perspectives in diagnosis, pathogenesis and management

Lunchtime session
Chairs: F. Morell Brotad (Barcelona, Spain), K. Brown (Denver, United States of America)
Aims: 1.Increase awareness of hypersensitivity pneumonitis(HP) in patients with new onset interstitial lung disease(ILD) or in newly detected ILD 2. Prompt early diagnosis and treatment intervention for HP 3 Provoke much needed clinical studies /clinical trials to treat patients with fibrotic stages of HP 4. Provoke major respiratory societies such as the ERS and ATS to sponsor development of the much needed clinical practice guidelines for diagnosis and management of HP

Introduction F. Morell Brotad (Barcelona, Spain)
Hypersensitivity pneumonitis (HP): diagnostic approach and classification - new perspectives G. Raghu (Seatle, United States of America)
Pathology of hypersensitivity pneumonitis (HP) J. Myers (Ann Arbor, United States of America)
Pathogenisis of hypersensitivity pneumonitis (HP) - current concepts  M. Vasakova (Prague, Czech Republic)
Treatment of hypersensitivity pneumonitis (HP) - targeting pathways of inflammation and fibrosis T. Maher (St. Albans, Hertfordshire, United Kingdom)